Novartis stock price traded near $99

US $240.00
List price US $409.000 (34% off)
777 sold
This one's trending. 34240 have already sold.
Breathe easy. Returns accepted.

Novartis stock price traded near $99.45 in today's session, showing a modest 0.6% gain amid broader healthcare sector strength. Analysts note steady revenue growth and upcoming pipeline updates as drivers for short-term momentum in pharma equities. Shares in Switzerland’s Roche Holding and Britain’s AstraZeneca—both sector heavyweights—jumped more than 5%. Other big drugmakers such as Denmark’s Novo Nordisk, Switzerland’s Novartis, France’s Sanofi and Britain’s GSK all traded higher. Smaller companies like Germany’s Merck KGaA, Belgium’s UCB and Argenx, Denmark’s Zealand Pharma and London-listed Hikma Pharmaceuticals also gained more than 4%. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. At $99.25, Novartis stock price remains firmly in its 50-day moving average channel, a positive technical indicator. Fundamental outlook is reinforced by diversified drug portfolio revenue streams.